Course of treatment response in first-episode and chronic schizophrenia
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The timing and clinical correlates of symptom change following antipsychotic treatment were examined in first-episode and chronic schizophrenia. METHOD: The subjects were 36 first-episode schizophrenic patients who had received minimal or no neuroleptics and 34 patients with chronic illness whose neuroleptics had been withdrawn. They were followed for 2 years and assessed with the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms. Treatment decisions during follow-up were made clinically by the treating physicians. RESULTS: At 6-month follow-up, both the neuroleptic-naive and previously treated patients showed significant improvement in positive symptoms (52% and 44% reductions from baseline, respectively). The previously treated but not the neuroleptic-naive patients also showed a significant reduction in negative symptoms (19% from baseline). A longer duration of illness before baseline assessment and inconsistent treatment during follow-up were independently associated with poorer treatment outcome in terms of positive symptoms in both groups. There were no significant changes on the outcome measures in either group after the 6-month follow-up. CONCLUSIONS: The results suggest that maximum symptomatic improvement occurs within the first 6 months of treatment and that disease progression may blunt treatment efficacy in both first-episode and chronic schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroleptics and the Natural Course of Schizophrenia
Wyatt, R. J. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.325 · Cited by 787
Gender differences in the clinical expression of schizophrenia
Shtasel, D. L., Gur, R. E., Gallacher, F., Heimberg, C., & Gur, R. C. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90016-x · Cited by 176
Cited by
Marshall, M., Lewis, S., Lockwood, A., Drake, R., Jones, P., & Croudace, T. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.975 · Cited by 1,593
Perkins, D. O., Gu, H., Boteva, K., & Lieberman, J. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1785 · Cited by 1,346
Lieberman, J. A., Perkins, D., Belger, A., Chakos, M., Jarskog, F., Boteva, K., & Gilmore, J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01303-8 · Cited by 593
Gur, R. E., Cowell, P., Turetsky, B. I., Gallacher, F., Cannon, T., Bilker, W., & Gur, R. C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.145 · Cited by 540
“Clinically, the patients’ presentation was comparable to that observed in larger samples.(42,43) The neuropsychological profile was also similar to that reported in schizophrenia, showing differential deficits in abstraction, attention, and verbal memory(35-38) and no differences between FE and PT patients.”
ResultSelf-citationIs schizophrenia a neurodegenerative disorder? a clinical and neurobiological perspective
Lieberman, J. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00147-x · Cited by 483
Duration of untreated psychosis: a critical examination of the concept and its importance
NORMAN, R. M. G., & MALLA, A. K. (2001) · Psychological Medicine · doi:10.1017/s0033291701003488 · Cited by 482
Predictors of Treatment Response From a First Episode of Schizophrenia or Schizoaffective Disorder
Robinson, D. G., Woerner, M. G., Alvir, J. M. J., Geisler, S., Koreen, A., Sheitman, B., Chakos, M., Mayerhoff, D., Bilder, R., Goldman, R., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.544 · Cited by 466
Subcortical MRI Volumes in Neuroleptic-Naive and Treated Patients With Schizophrenia
Gur, R. E., Maany, V., Mozley, P. D., Swanson, C., Bilker, W., & Gur, R. C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1711 · Cited by 434
Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course?
McGlashan, T. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00084-0 · Cited by 374
Lieberman, J. A., Phillips, M., Gu, H., Stroup, S., Zhang, P., Kong, L., Ji, Z., Koch, G., & Hamer, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300157 · Cited by 345
The Varied Outcomes of Schizophrenia
Davidson, L., & McGlashan, T. H. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200105 · Cited by 308
First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome
Malla, A. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi031 · Cited by 288
Kim, Y.-K., & Shin, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915141036 · Cited by 271
Ho, B.-C., Andreasen, N. C., Flaum, M., Nopoulos, P., & Miller, D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.808 · Cited by 259
Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS)
Singh, S. P., Cooper, J. E., Fisher, H. L., Tarrant, C. J., Lloyd, T., Banjo, J., Corfe, S., & Jones, P. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.018 · Cited by 252
Superior temporal gyrus and the course of early schizophrenia: Progressive, static, or reversible?
Keshavan, M. S., Haas, G. L., Kahn, C. E., Aguilar, E., Dick, E. L., Schooler, N. R., Sweeney, J. A., & Pettegrew, J. W. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00038-1 · Cited by 198
Sexuality, Reproduction, and Family Planning in Women With Schizophrenia
Miller, L. J. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.623 · Cited by 181
“Furthermore, discontinuing medications during pregnancy may adversely influence the life course of the woman's illness, as greater consistency of antipsychotic treatment results in significantly greater improvement over time (Szymanski et al. 1996).”
BackgroundNegative symptoms in first episode non‐affective psychosis
Malla, A. K., Takhar, J. J., Norman, R. M. G., Manchanda, R., Cortese, L., Haricharan, R., Verdi, M., & Ahmed, R. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2002.02139.x · Cited by 118
Jablensky, A. (2003) · Schizophrenia · doi:10.1002/9780470987353.ch12 · Cited by 59
Kimura, H., Kanahara, N., Komatsu, N., Ishige, M., Muneoka, K., Yoshimura, M., Yamanaka, H., Suzuki, T., Komatsu, H., Sasaki, T., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.022 · Cited by 55
Determining the optimal dose of haloperidol in first-episode psychosis
Oosthuizen, P., Emsley, R. A., Turner, J., & Keyter, N. (2001) · Journal of Psychopharmacology · doi:10.1177/026988110101500403 · Cited by 48
Early psychosis treatment in an integrated model within an adult mental health service
Petrakis, M., Penno, S., Oxley, J., Bloom, H., & Castle, D. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.03.004 · Cited by 26
Gaudiano, B., Davis, C., Epstein-Lubow, G., Johnson, J., Mueser, K., & Miller, I. (2017) · Healthcare · doi:10.3390/healthcare5020023 · Cited by 22
“, first episode versus chronic psychosis) may be important to examine due to its relationship with outcome in schizophrenia [94].”
BackgroundEgger, S. T., Vetter, S., Weniger, G., Vandeleur, C., Seifritz, E., & Müller, M. (2016) · Frontiers in Public Health · doi:10.3389/fpubh.2016.00220 · Cited by 6
“The missing association between the number of previous hospitalizations and subsequent functional change seems to contradict previous findings that suggested that patients with chronic schizophrenia generally tend to have poorer outcomes than first-episode patients (41), but since our data were limited to previous adm…”
Result
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1996-04-01
- Volume
- 153
- Issue
- 4
- Pages
- 519-525
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W202304088
- Cited by
- 154
- References
- 2
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.